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ABSTRACT This article demonstrates that the threshold response of initiation of blood clotting to the size of a patch of stimulus is
a robust phenomenon under awide range of conditions and follows a simple scaling relationship based on theDamko¨hler number.
Human blood and plasma were exposed to surfaces patterned with patches presenting clotting stimuli using microﬂuidics.
Perturbations of the complex network of hemostasis, including temperature, variations in the concentration of stimulus (tissue
factor), and the absence or inhibition of individual components of the network (factor IIa, factor V, factor VIII, and thrombomodulin),
did not affect the existence of this response. A scaling relationship between the threshold patch size and the timescale of reaction
for clotting was supported in numerical simulations, a simple chemical model system, and experiments with human blood plasma.
These results may be useful for understanding the spatiotemporal dynamics of other autocatalytic systems and emphasize the
relevance of clustering of proteins and lipids in the regulation of signaling processes.
INTRODUCTION
This article describes experiments and numerical simulations
to characterize the threshold response of blood clotting to the
size of a patch presenting a clotting stimulus. Understanding
the dynamics of blood clotting is important to biomedical
applications as well as the study of complex networks. The
spatiotemporal dynamics of initiation of blood clotting is par-
ticularly interesting, as blood clottingmust initiate and remain
localized at sites of vascular damage, and common clotting
disorders are related to the failure of this process. Under-
standing how initiation of blood clotting is regulated is dif-
ficult, as it involves simultaneous consideration of the entire
complex network of clotting reactions as well as the spatial
and temporal effects associated with the vascular system.
Numerous experimental and theoretical studies have
provided valuable insight into how initiation of clotting is
regulated. Transport of activators and inhibitors of clotting by
both diffusion and convection (fluid flow) has been proposed
to contribute to the regulation of initiation of surface reactions
in blood clotting (1–8). Experimental studies have shown that
reactions in the clotting network are regulated, in part, by a
threshold response to the concentration of activators in
solution (9–11). Additional theoretical studies proposed that
this thresholdmay be controlled by transport of activators and
influenced by the size of a patch of vascular damage (1,4) as
well as the concentrations of stimuli on a patch (3).
Our previous experiments (4) demonstrated that initiation
of clotting of pooled platelet-poor plasma (pooled-PPP) dis-
played a threshold response to the size of a patch presenting
a clotting stimulus. In addition, we hypothesized that the
threshold patch size necessary to initiate clotting could be
quantitatively predicted by a scaling relationship based on the
Damko¨hler number, Da, which describes the competition
between reaction and diffusion of molecules (12–14). Here,
we extend previous work to demonstrate that the threshold
response of initiation of clotting to patch size is a robust
phenomenon under a wide range of conditions. Our goal was
not to reproduce all of the conditions present in vivo, but to
test the threshold response against a set of well-defined con-
ditions. In addition, we test a scaling relationship between the
critical size of a patch of stimulus needed to initiate clotting
and the timescale of reaction for clotting. This scaling re-
lationship was supported in numerical simulations and in ex-
periments with both a nonbiological, chemical system and
human blood plasma.
MATERIALS AND METHODS
All solvents and salts used in buffers were purchased from commercial
sources and used as received unless otherwise stated.
Poly(dimethylsiloxane) (PDMS, Sylgard Brand 184 Silicone Elastomer
Kit) was purchased from Dow Corning (Midland, MI).
1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), L-a-phosphatidyl-
serine fromporcine brain, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were purchased
from Avanti Polar Lipids, (Alabaster, AL).
Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (Texas
Red DHPE), n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-
glycero-3-phosphoethanolamine triethylammonium salt (NBD-PE), and
rhodamine 110-bis-(p-tosyl-L-glycyl-L-prolyl-L-arginine amide) were pur-
chased from Molecular Probes/Invitrogen (Eugene, OR).
T-butyloxycarbonyl-b-benzyl-L-aspartyl-L-prolyl-L-arginine-4-methyl-
coumaryl-7-amide (Boc-Asp(OBzl)-Pro-Arg-MCA) and t-butyloxycarbonyl-
Leu-Ser-Thr-Arg-4-methylcoumaryl-7-amide (Boc-Leu-Ser-Thr-Arg-MCA)
were purchased from Peptides International (Louisville, KY).
Albumin from bovine serum, alginic acid, and 2-nitrobenzaldehyde were
purchased from Sigma (St. Louis, MO).
Argatroban was obtained from GlaxoSmithKline (Research Triangle
Park, NC).
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Human recombinant tissue factor (TF), human thrombin, and corn trypsin
inhibitor were purchased from Calbiochem/EMB Biosciences (La Jolla,
CA).
Rabbit lung thrombomodulin (TM) and human protein C were obtained
from American Diagnostica (Stamford, CT).
Bromophenol blue and sodium chlorite (NaClO2, 80% purity) were pur-
chased from Acros Organics (Morris Plains, NJ).
Krytox fluorinated grease is a product of Dupont (Wilmington, DE).
Sodium thiosulfate (Na2S2O3, 99.9% purity) and anhydrous methyl
sulfoxide (DMSO, 99.7% purity) were purchased from Fisher Scientific
(Fair Lawn, NJ).
Dimethylsiloxane-ethylene oxide block copolymer was purchased from
Gelest (Morrisville, PA).
Siliconized coverslips were obtained from Hampton Research (Aliso
Viejo, CA).
Normal pooled plasma (human, platelet poor) was purchased from
George King Bio-Medical (Overland Park, KS).
Human whole blood was obtained from individual healthy donors in
accordance with the guidelines set by the Institutional Review Board
(protocol # 12502A) at The University of Chicago.
Generating patches of tissue factor (TF)
surrounded by an inert phospholipid bilayer
The methods used here to prepare lipid vesicles and bilayers have been
previously described (4). The inert lipid bilayer contained 97 mol % of
DPPC and 3% of a green fluorescent dye (NBD-PE) (4). In experiments with
TM reconstituted into the lipid bilayer, the inert bilayer consisted of a lipid
mixture of DMPC (48.5%), DPPC (48.5%), and 3%NBD-PE, and contained
thrombomodulin (TM) at a calculated concentration of 40 pmol/m2 (actual
ratio of TM/lipids ¼ 1.3 3 105). TM was incorporated into vesicles as
previously described (15).
In the control experiment to determine the activity of TM in the phos-
pholipid bilayer, the rate of protein C activation in the presence of thrombin
was measured (16). A function of TM is to convert protein C to activated
protein C (APC) when thrombin binds to TM (17,18). The concentration of
APC was determined using an APC-sensitive fluorogenic peptide dye, Boc-
Leu-Ser-Thr-Arg-MCA (19). A solution containing 0.1 mM of the fluoro-
genic peptide dye, 5 nM human thrombin, 800 nM human protein C, 0.1%
bovine serum albumin, 5 mM CaCl2, 20 mM TRIS, and 100 mMNaCl (final
pH 7.5) was prepared and immediately placed in contact with the phos-
pholipid bilayer reconstituted with TM. The blue fluorescence intensity was
measured every 5 min for up to 3 h. The sample was stirred gently between
measurements. APC production was determined based onMichaelis-Menten
kinetics and known kinetics for the APC fluorogenic dye (19). Thrombin is
known to activate protein C directly and to slowly activate the APC fluoro-
genic dye. Thus, the background fluorescence, measured in control samples
containing no TM, was subtracted from the measured fluorescence intensity
in samples containing TM. For a bilayer containing a calculated TM concen-
tration of 40 pmol/m2, APC production was 35 pmol/min/m2, which is on
the same order of magnitude as previously measured for a monolayer of
endothelial cells (20).
A photomask patterned with circular patches of different sizes was placed
over the inert bilayer and irradiated with deep UV light. The patterned
bilayer was backfilled with vesicles containing 79.5 mol % of DLPC, 20 mol
% of porcine brain, 0.5 mol % of a red fluorescent dye (Texas Red DHPE),
and TF (concentrations between 0.3 and 8 pmol/m2).
Measuring initiation time of human blood and
plasma on patches of TF
Pooled platelet-poor plasma (pooled-PPP) was used as received from the
commercial source. Whole blood obtained from donors was collected in
Vacutainer tubes (Becton-Dickinson, Franklin Lakes, NJ) containing 3.2%
sodium citrate (9:1 by volume). Platelet-rich plasma (PRP) was obtained by
centrifuging whole blood at 300 g for 10 min. PPP was obtained by
centrifuging whole blood at 800 g for 10 min, then centrifuging the plasma
again at 800 g for 10 min. All blood and plasma were incubated with corn
trypsin inhibitor (100 mg/mL) to inhibit the factor XII pathway of initiation
of clotting (21). Citrated pooled-PPP, PRP, and PPP (300 mL) were re-
calcified by adding a solution of CaCl2 containing a thrombin-sensitive fluo-
rescent substrate, Boc-Asp(OBzl)-Pro-Arg-MCA (100 mL, 40 mM CaCl2,
90 mMNaCl, and 0.4 mMBoc-Asp(OBzl)-Pro-Arg-MCA). Argatroban was
added to the pooled-PPP at desired concentrations of 0 to 2.5 mg/mL. To
recalcify whole blood (22), the whole blood (376 mL) was mixed with
a thrombin-sensitive fluorescent substrate, rhodamine 110-bis-(p-tosyl-L-
glycyl-L-prolyl-L-arginine amide) (2 mL, 10 mM in DMSO), and then added
to a solution of CaCl2 (23.5 mL, 200 mM). Recalcified whole blood or
plasma (400 ml) was placed in contact with the patterned bilayer substrate in
a microfluidic chamber (4). Initiation of clotting was measured by moni-
toring the formation of thrombin and fibrin. The formation of thrombin was
monitored by fluorescence microscopy to detect the cleavage products from
the thrombin-sensitive fluorescent substrates. The formation of fibrin was
detected using bright-field microscopy.
Measuring initiation time of the nonbiological,
chemical system on patches of acid
The reaction solution in the nonbiological, chemical systemwas composed of
equal parts of two precursor aqueous solutions: 1), sodium thiosulfate
(Na2S2O3, 0.492mmol), alginic acid (5.8 mg/mL), and bromophenol blue
(0.425 mM) with a final pH 7; and 2), sodium chlorite (NaClO2, 2.99 mmol,
pH10.7) (7,23). The photoacid-coated substratewas prepared by spin-coating
a siliconized coverslip with a 20–30 mm thick layer of 2-nitrobenzaldehyde
(50% by weight) in dimethylsiloxane-ethylene oxide block copolymer. The
reaction solution was placed in contact with the photoacid substrate in a
microfluidic chamber (4). UV light (300–400 nm) was irradiated on a photo-
mask (CAD Art Services, Bandon, OR) and passed through clear patches to
generate H1 only in specific areas. Initiation of the chemical systemwasmea-
sured by monitoring the fluorescence of bromophenol blue, a pH-sensitive
dye, by fluorescence microscopy.
Fabricating the microﬂuidic chambers
The microfluidic chambers used in the blood and plasma experiments were
prepared from PDMS cured on multilevel, machine-milled brass masters.
Disposable devices were generated with an inner diameter of 13mm, an outer
diameter of 20 mm, and a depth of 1 mm. The microfluidic chamber used in
the nonbiological, chemical system experiment consisted of a PDMS gasket
with an inner diameter of 10 mm, an outer diameter of 20 mm, and a depth of
1 mm. The gasket was sealed to a siliconized coverslip and to the photoacid-
coated substrate.
Analysis of ﬂuorescence images
Image analysis was preformed as previously described (4). The original gray-
scale fluorescence images were collected and false-colored using MetaMorph
software (Molecular Devices, Sunnyvale, CA). For each wavelength, the
levels were adjusted to the same values. Images were overlaid using Adobe
Photoshop software (Adobe, San Jose, CA).
Numerically simulating initiation of an
autocatalytic system on different sized patches
Numerical simulations were performed using a commercial finite element
package (Comsol Multiphysics 3.2, Comsol, Stockholm, Sweden). Three
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rate equations were utilized in the simulation: 1), production of activator, C,
at the surface of the patch, rate ¼ kpatch,; 2), autocatalytic production of C in
solution, rate ¼ kprod[C]21 b (kprod ¼ 23 107 M1/s, b ¼ 23 1010 M/s);
and 3), linear consumption of C in solution, rate¼ –kconsum[C] (kconsum[C]¼
0.2 s1). kpatch, was varied from 2.5 3 10
8 to 1 3 106 M/s to obtain
different values of tr. The initial concentration of C was 13 10
9 M, and the
diffusion coefficient was 5 3 1011 m2/s. Rate constants were based on
known values for reactions in the blood clotting network (5).
RESULTS
Testing the robustness of the threshold response
To test whether the threshold response of clotting on patches
is a robust phenomenon, wemeasured the clot times of human
blood and plasma on arrays of patches of varying sizes under
a variety of conditions. We used pooled platelet-poor plasma
(pooled-PPP), platelet-poor plasma (PPP), platelet-rich
plasma (PRP), and whole blood to test the influence of
platelets and blood cells on the threshold phenomenon. In
addition, we tested the influence of temperature (24 and 37C)
on the threshold response in pooled-PPP and PRP. Using
pooled-PPP, we also tested the influence of a membrane-
bound inhibitor of clotting, thrombomodulin (TM) (17,18,20,
24), on the threshold response. To determine whether the
threshold response was robust in blood from patients with
clotting disorders, we tested factor V deficient PPP and
factor VIII deficient PPP. We also tested the effect of a factor
IIa (thrombin) deficiency on the clotting response by adding
argatroban (25), an inhibitor of factor IIa, to pooled-PPP.
Patches consisted of circular areas of a planar phospho-
lipid bilayer (26–28) reconstituted with a clotting stimulus
tissue factor (TF) (Fig. 1 a) (11,29). Patches were surrounded
by an inert phospholipid bilayer (Fig. 1 b) (4). For these
experiments testing the robustness of the threshold response,
the concentration of TF in the phospholipid bilayer was;0.5
pmol/m2, but fluctuations in the activity of TF from day to
day were observed. To account for slight variations in TF
concentration or activity in the phospholipid bilayer between
experiments, a control using pooled-PPP was performed for
each set of conditions. For experiments testing the influence
of TM on the threshold response, TM was reconstituted into
the inert phospholipid bilayer (15,30). Clotting was indicated
by the appearance of both thrombin and fibrin. The formation
of fibrin was monitored by bright-field microscopy, and the
formation of thrombin was monitored by fluorescence mi-
croscopy, where the concentration of a thrombin-sensitive
dye (blue) was measured (Fig. 1 c) (21,31). Blood plasma
was placed on arrays of patches of different sizes, and clot
time on each patch was measured. Qualitatively, clotting
always occurred on large patches, but not on small patches.
To test the existence of a threshold response, we measured
clot time versus patch size for each condition. Clotting of
pooled-PPP, PPP, and PRP displayed a threshold response to
patch size (Fig. 2, a–e). In comparison to pooled-PPP and PPP
from a single donor, data from experiments with PRP showed
more scatter due to increased spontaneous clotting. Whole
blood (Fig. 2 f) demonstrated even greater spontaneous clot-
ting,where clotting occurredwithin 20min in all experiments,
even in experiments with no patches of stimulus. As a result, it
was difficult to measure the threshold response in whole
blood. While there is a clear transition from slow clotting on
patches smaller than 60mm to faster clotting on patches larger
than 80 mm (Fig. 2 f), we are hesitant to refer to this transition
as a threshold response. To conclusively test whether the
threshold dynamics is relevant with whole blood, improve-
ments to the experimental setup are essential, including better
control of surface chemistry of microfluidic devices (32–35).
Specifically, modification of the bilayer surface by varying
lipid composition and membrane protein composition
should improve the background clotting time. Additionally,
improving the delivery of blood from the patient to the
chamber, such as by directly transferring the blood without
adding citrate, should improve the experiment. Temperature
did not substantially affect the existence of the threshold
response in either pooled-PPP (Fig. 2, a and b) or PRP (Fig. 2,
c and d).
To determine the influence of TM on the threshold
response, we monitored clotting of pooled-PPP on patches
of TF surrounded by an inert bilayer reconstituted with
TM. The calculated TM concentration in the bilayer was
FIGURE 1 Micrographs showing initiation of clotting
of platelet-rich plasma on patches of TF reconstituted in a
phospholipid bilayer. (a) Lipid tagged with red dye was
incorporated into a phospholipid bilayer containing phos-
phatidylcholine, phosphatidylserine, and reconstituted TF.
(b) Lipid tagged with green dye was incorporated into an
inert phospholipid bilayer containing phosphatidylcholine.
(c) Blue fluorescent dye indicated a high concentration of
thrombin, an indicator of clotting. Clotting occurred on
patches $165 mm, but not on patches #90 mm.
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40 pmol/m2, and control experiments confirmed that TM was
active (see Materials and Methods) (16). The presence of TM
in the inert bilayer did not affect the existence of the
threshold response (Fig. 3). It is has been shown conclu-
sively that TM is a potent anticoagulant in both in vitro and
in vivo studies (18,20,24). The inability of TM to prevent
clotting on large patches of stimulus in our experiments does
not necessarily contradict these studies. In one study, TM
was shown to produce activated protein C (APC) with a
delay of a few minutes after exposure to thrombin (36). If
these results are applicable to our experiments, then inhibi-
tion of clotting in the presence of TM would occur after
initiation took place. Also, TM in capillaries is believed to be
a sink for circulating thrombin, and therefore may act
systemically by lowering the steady-state concentration of
thrombin. Since our experiments focused on observing the
local response, this systemic response would not be detected.
Finally, TM is believed to be most important in small
capillaries with high surface/volume ratios (18,37). Our ex-
periments have lower surface/volume ratios than capillaries.
PPP deficient in factor V or factor VIII and PPP with
partially inhibited factor IIa (thrombin) also displayed a
threshold response (Fig. 4). Plasmas deficient in factor V or
factor VIII were from human donors with congenial enzyme
deficiencies. Argatroban, an inhibitor of factor IIa currently
used as an anticoagulant drug, was added directly to pooled-
PPP at 1 mg/mL and 2.5 mg/mL to partially inhibit factor IIa.
These results show that the existence of the threshold response
remains robust even when the concentration of individual
components of the hemostasis network is reduced.
Formulating and testing a physical description
of the threshold response
We utilized experimentally observable, physical parameters
to develop a simplified description of the threshold response.
FIGURE 2 Testing the existence of the threshold response of clotting to patch size in several types of human blood plasma and whole blood at 24 and 37C.
Data points on and above the dashed line represent patches that did not clot within 45 min, when the experiments were stopped. Some data points have been
shifted above the line to allow for visualization of overlaid data points.
FIGURE 3 Testing the influence of thrombomodulin
(TM) on the existence of the threshold response of clotting
to patch size. The presence of TM did not affect the ex-
istence of the threshold response in pooled-PPP.Data points
on the dashed line represent patches that did not clot within
45 min, when the experiments were stopped.
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We previously proposed a scaling relationship based on the
Damko¨hler number to describe initiation of a reaction on
patches of surface stimuli (4). The Damko¨hler number is
commonly used to predict the outcome of chemical reactions
in systems that include mass transport, based on the compe-
tition between reaction and transport (12–14). A threshold
response is manifested by the initiation of a reaction only
when the concentration of activators exceeds the threshold
concentration. Therefore, initiation of a reaction is dependent
on competition between the timescale of reaction, tr, for
production of activators on the patch and the timescale of
diffusion, tD, for diffusive transport of activators off the
patch (Fig. 5). The magnitude of the Damko¨hler number,
Da ¼ tD / tr, is dictated by the diameter of the patch, p. Small
p corresponds to small tD and small Da, as diffusion of
activators off of the patch occurs rapidly, whereas large p
corresponds to large tD and largeDa, as activators take a long
time to diffuse away from the patch.
Initiation will occur at large Da when tr is fast and tD is
slow. Diffusion is described by a simple scaling equation,
tD } p
2/D, where tD is the timescale of diffusion [s], p is the
patch size [m], and the D is the diffusion coefficient for a
particular molecule [m2/s]. This equation can be used to
describe the threshold patch size, ptr, above which initiation
occurs. Thus ptr should scale with t
1=2
r according to ptr }
(D 3 tr)
1/2.
First, we wished to determine whether the scaling predic-
tion was reasonable for a system with diffusion and boundary
conditions in three dimensions. To address this question, we
used three-dimensional numerical simulations of a simple,
autocatalytic system with a threshold response that was ac-
tivated by patches of stimulus. The rate and diffusion con-
stants used in these simulations were on the same scale as
those of known blood clotting components (5). To model an
autocatalytic system with a threshold response, two rate
equations were incorporated—one that described autocata-
lytic production of activator, and one that described linear
consumption of activator (see Materials and Methods). This
type of autocatalytic system was previously proposed to ac-
count for the threshold response in the hemostasis network
(7,38). These simulationswere performed using a commercial
software package (Comsol Multiphysics 3.2).
FIGURE 4 Testing the existence of the threshold response of clotting to patch size for plasmas deficient in active clotting enzymes. (a,b) Pooled-PPP
deficient in factor V or factor VIII displayed a threshold response. (d,e) Pooled-PPP with factor IIa inhibited by argatroban at two different concentrations also
displayed a threshold response. The control experiment for panels a and b is shown in panel c, and the control experiment for panels d and e is shown in panel f.
Data points on the dashed line represent patches that did not clot within 45 min, when the experiments were stopped.
FIGURE 5 Competition between diffusion, D (black arrows), and
reaction, R (blue arrows), of activators determines whether initiation will
occur on a given patch (orange). The timescale of diffusion is dependent on
patch size, whereas the timescale of reaction is independent of patch size. (a)
When p is large, diffusion is slower than reaction, and initiation occurs.
Within the timescale of reaction, diffusion only removes activators from the
edge of the patch, allowing a high concentration of activators to accumulate
in the center. (b) When p is small, diffusion is faster than reaction, and
initiation does not occur. Diffusion is able to remove activators from the
entire patch before initiation of reaction can occur.
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To compare the relationship between ptr and tr, we first
determined the value of tr for several rates of production
from a uniform surface of stimulus. The value of tr was equal
to the initiation time on an infinitely large patch of stimulus
with a given rate of production from the surface. Then, we
varied p for each tr to determine ptr. As expected, a threshold
patch size existed for each tr (Fig. 6 a), where p. ptr resulted
in initiation and growth in three dimensions, and p , ptr did
not initiate. A plot of ptr versus tr showed a one-half power
scaling relationship (Fig. 6 b) and verified that the scaling
predictionwas reasonable for systemswith three-dimensional
diffusion in the presence of realistic boundary conditions
resembling those in experiments described above.
Next, we experimentally tested the predicted scaling re-
lationship by using a simple, nonlinear chemical system (7,
23,39–41) composed of three reactions. This chemical system
is a simple, autocatalytic systemwith a threshold response and
has been shown to reproduce the nonlinear dynamics of
initiation of blood clotting (4,7). Initiation of this autocatalytic
system occurs at a critical concentration of activator, the
hydronium ion (H3O
1). Initiation is ‘‘all or nothing,’’ cor-
responding to a switch from basic to acidic conditions and is
accompanied by precipitation. In this experiment, patches of
acid were selectively produced by irradiating a photoacid
layer on the surface through a photomask (4). Different values
of tr were obtained by adjusting the intensity of the irradiation
and thus the production of acid from the surface. For each tr, a
specific value of ptr wasmeasured. A plot of ptr versus tr shows
a linear relationship, with a one-half power regression falling
within a 97.5% confidence interval of the best fit regression
(Fig. 7 a), and experimentally supports the scaling prediction.
To demonstrate the applicability of the scaling prediction to
complex, biological systems, we tested it by using human
pooled-PPP. Initiation of blood clotting occurs at a critical
concentration of activators, such as thrombin, and results in
autocatalytic production of activators, precipitation of fibrin,
and the subsequent formation of a solid clot (11). The stimulus
for production of activators in vivo is the enzyme TF. To
determine if the scaling prediction applies to blood clotting,
we measured the tr of human blood plasma exposed to
surfaces of phospholipid bilayer containing TF in a micro-
fluidic chamber (4). To vary tr in these experiments, we varied
two parameters: 1), the concentration of TF on the surfacewas
varied from 0.3 to 8 pmol/m2; and 2), the concentration of
argatroban, an inhibitor of thrombin, in solution was varied
from 0 to 2.5mg/mL. Tomeasure ptr, patches of TF of specific
sizes were created through a photopatterning process (26,27).
For each tr, a specific value of ptr was measured (Fig. 7 b).
A plot of ptr versus tr shows a linear relationship, with a
one-half power regression falling within a 97.5% confidence
interval of the best fit regression (Fig. 7 b). A plot of ptr
versus tr with raw (nonaveraged) data also shows the one-
half power regression falling within a 97.5% confidence
interval of the best fit regression. As expected for complex
biological systems, the amount of scatter in the data was
greater in comparison to the numerical simulation and the
nonbiological chemical system. Due to this scatter, it is not
possible to rule out similar scaling hypotheses. Specifically,
it is not possible to rule out a scaling hypothesis with a power
of two-thirds, as a two-thirds power regression also falls
within a 97.5% confidence interval of the best fit regression.
However, it is possible to reject, with .97.5% confidence,
the scaling hypotheses with powers of 1 and larger and with
powers of one-third and smaller. Thus, at least for this in
vitro system, a scaling relationship exits between ptr and tr,
and the scaling power is within a factor of two of that
predicted by the chemical model.
DISCUSSION
We have shown that the threshold response of blood clotting
to the size of a patch of stimulus is a robust phenomenon under
a wide range of conditions. Perturbations of this complex
network, such as temperature, variations in the concentration
of stimulus, and the absence or inhibition of individual
components of the network, did not affect the existence of this
response. These studies still do not include many important
aspects of coagulation in vivo, and in vivo studies are needed
to determine the physiological relevance of these threshold
dynamics. Our goal was not to reproduce all of the conditions
present in vivo, but to test the threshold response against a set
of well-defined conditions. Additional components that may
FIGURE 6 Three-dimensional numerical simulations
of initiation of clotting show a one-half power scaling
relationship between ptr and tr. (a) Initiation time versus p
curves show that a specific ptr exists for reach tr. Each
curve corresponds to a particular tr indicated by the value
to the right of the curve (units of seconds), and ptr
corresponds to the inflection point of each curve. (b) A plot
of ptr versus tr for each curve in panel a shows a one-half
power scaling relationship. The reference regression, y ¼
1/2x 1 c (shaded), falls within a 99% confidence limit
(dotted lines) of the best fit linear regression (solid). The
slope of the best fit linear regression was 0.54, and the
r-value was r ¼ 0.99.
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influence the existence of the threshold response include the
presence of cells of the vascular wall and additional three-
dimensional microgeometries. While we did not focus on the
role of transport by flow in these experiments, flow is certain
to affect the threshold response in these systems, as it is known
to be important for regulating clotting in vivo. One may
expect that flow would act similar to diffusion, removing
activators from the patch, leading to larger threshold patch
sizes. An important extension of this work would be to test
the influence of flowon the threshold patch size.Development
of flow chambers with controlled shear (36,42) that are com-
patible with the lipid patterning techniques (26–28) is a
challenge that needs to be addressed. Although not every
component involved in hemostasis was tested, the results here
show that the threshold is robust for a large range of con-
ditions. These results imply that a mechanism based on
physical parameters, not the individual reactions within the
network, governs the threshold response, and this mechanism
may be fundamental to threshold responses in other autocat-
alytic systems. These results support our previous assertion
that the reactions of the hemostasis network display amodular
organization, which may explain the robustness of the thres-
hold response.
To provide a physical description of the threshold response,
we predicted a one-half power scaling relationship between
the critical size of a patch of stimulus necessary to initiate
clotting and the timescale of reaction for clotting. While the
one-half power scaling relationship was strongly supported in
both a numerical simulation and in experiments with a simple,
nonlinear chemical system, experiments with pooled-PPP did
not display a scaling relationship of exactly one-half power. It
remains to be seen if this discrepancy is due to the difficulty of
performing experiments with blood, or due to the higher
complexity of blood and its underlying dynamics. Also, in
these experiments, the threshold value was measured across
almost three orders of magnitude of tr, and it is possible that
our simplification loses accuracy across such a wide range of
perturbation. Another possibility is that the dynamics of the
chemical model may have been incorrectly interpreted, and
the true scaling relationship may be different from the pro-
posed equation. Nonetheless, the agreement between the
dynamics observed in the numerical simulation, the chemical
system, and blood plasma is surprising. It is particularly
interesting that a property of a complex network, such as ptr in
blood clotting, can scale over almost three orders of mag-
nitude. There are several possible explanations for this result
that may be elucidated by future research: 1), most of the
activators of clotting may have similar diffusion coefficients;
2), many of the autocatalytic reaction loops may have similar
timescales of reaction; or 3), the timescale of one reaction in
the network may be dominant in determining whether initi-
ation occurs or not.
This scaling prediction and future research aimed at
providing a better understanding of the threshold response
in blood clotting may lead to improved point of care
diagnostic tools and drug therapies. Current clinical diagnos-
tic tests, including activated partial thromboplastin time and
prothrombin time, do not closely mimic the spatiotemporal
dynamics of initiation of clotting in vivo, and a more accurate
physical description of clotting could allow the development
of improved methods. In addition, the ability to quantify a
change in tr resulting from a change in the dosage of a drug
should enable the correct prediction of the potential of a
patient’s blood to clot at varying doses, and may allow more
precise administration of drugs. Of course, some difficulties
must be overcome for in vivo application of this scaling
prediction, such as reducing spontaneous clotting in whole
blood and further characterization of its potential to measure
changes in the ability of a patient’s blood to clot.
This characterization of the relationship between the
timescale of reaction and the critical patch size necessary to
initiate a reaction should also be useful for understanding
initiation of other autocatalytic systems that demonstrate a
threshold response. Understanding dynamics of patches is im-
portant, as the clustering of proteins and lipids on membranes
maybe a common phenomenon in biological signaling path-
ways (43,44). Investigating the influence of additional
parameters, including transport by convection, changes in
boundary conditions, and the effect of a three-dimensional
stimulus on initiation will provide a more comprehensive
FIGURE 7 Comparing the experiments to the predicted
one-half power scaling relationship for (a) the simple,
nonlinear chemical system and (b) the complex system of
blood clotting. For both panels a and b, the reference
regression line, y¼ 1/2x1 c (shaded), falls within a 97.5%
confidence interval (dotted lines) of the best fit linear
regression (solid). The slope of the best fit linear regression
was (a) 0.61 and (b) 0.64. The r-value of the best fit linear
regressionwas (a) r¼ 0.98 and (b) r¼ 0.90. In panel a, each
data point corresponds to a single experimental value. In
panel b, each data point for tr is an average of three values of
ptr, except the point log tr ¼ 2.31, which contains only two
values of ptr. Error bars correspond to the maximum and
minimum values of ptr.
Threshold Response in Blood Clotting 2975
Biophysical Journal 93(8) 2969–2977
understanding of the spatiotemporal dynamics of complex,
nonlinear systems with patches bearing species involved in
autocatalysis and positive feedback loops.
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